Defense Threat Reduction Agency Leverages MRIGlobal Expertise in U.S. Government Efforts to Halt Epidemic. Completed labs scheduled to transport from Kansas City to Sierra Leone December 18.
Kansas City, Mo. – MRIGlobal today announced the deployment of specialized mobile clinical diagnostics laboratories designed and developed for use in Ebola treatment centers in Sierra Leone.
MRIGlobal's contract is with the Defense Threat Reduction Agency for two clinical diagnostic laboratories, outfitted with analytical equipment to quickly and accurately process samples to diagnose Ebola. These self-contained units include generators for powering the state-of-the-art facilities, along with systems for communications, clean water, storage, and living quarters.
"MRIGlobal proudly joins the national response against the Ebola epidemic," said Thomas M. Sack, Ph.D., President and Chief Executive Officer of MRIGlobal. "Our unique expertise in the design, development, and deployment of mobile systems is a valuable asset to the nation's Ebola response."
The completed labs will be transported from MRIGlobal in North Kansas City and loaded onto an Antonov An-124 Ruslan, a strategic airlift jet aircraft bound for Sierra Leone.
MRIGlobal has more than a decade of expertise in the design, development, and deployment of state-of-the-art mobile laboratories and related systems. Incorporating highly efficient electrical mini-grids, and ruggedized equipment, the mobile systems can be rapidly assembled or disassembled for transport.
"One of the most challenging aspects of Ebola is rapid diagnosis. Currently, it may take days for patient specimens to travel great distances to reference labs for diagnosis," Sack said. "Our labs bring the reference labs to the field enabling quick diagnosis. That means healthcare workers can quickly isolate Ebola patients, a critical step to decrease exposure and institute treatment protocols."